THE LELAND STANFORD JUNIOR UNIVERSITY - COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.

On Jan 7, 2026, Department of Health and Human Services obligated $25,640,419.95 to THE LELAND STANFORD JUNIOR UNIVERSITY for covid-19. to develop small synthetic chemical molecules as broadly active antiviral for the treatment of viral infections.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 23 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in STANFORD, CA. The contract is scheduled through May 31, 2030. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.